Phase 2 trial of talabostat and docetaxel in patients with stage IIIb/IV NSCLC

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7120-7120 ◽  
Author(s):  
C. Cunningham ◽  
D. Richards ◽  
R. Salgia ◽  
R. Leonard ◽  
R. Raju ◽  
...  
Keyword(s):  
Stage Iiib ◽  
Phase 2 ◽  
Phase 2 Trial

Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB–IVM1a melanoma: a randomized, open-label, phase 2 trial

2021 ◽  
Vol 27 (10) ◽  
pp. 1789-1796
Author(s):  
R. Dummer ◽  
D. E. Gyorki ◽  
J. Hyngstrom ◽  
A. C. Berger ◽  
R. Conry ◽  
...  
Keyword(s):  
Stage Iiib ◽  
Phase 2 ◽  
Talimogene Laherparepvec ◽  
Open Label ◽  
Phase 2 Trial ◽  
Open Label Phase

scholarly journals Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08)

2019 ◽  
Vol 120 (10) ◽  
pp. 968-974 ◽  
Author(s):  
Alessandra Curioni-Fontecedro ◽  
◽  
Jean Yannis Perentes ◽  
Hans Gelpke ◽  
Alexandros Xyrafas ◽  
...  
Keyword(s):  
Preoperative Chemotherapy ◽  
Stage Iiib ◽  
Phase 2 ◽  
Multicentre Phase ◽  
Phase 2 Trial

Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB–C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial

2019 ◽  
Vol 20 (7) ◽  
pp. 961-971 ◽  
Author(s):  
Georgina V Long ◽  
Robyn P M Saw ◽  
Serigne Lo ◽  
Omgo E Nieweg ◽  
Kerwin F Shannon ◽  
...  
Keyword(s):  
Stage Iiib ◽  
Phase 2 ◽  
Single Centre ◽  
Open Label ◽  
Phase 2 Trial

12-Month Follow-up From Phase 2 Trial of Liposomal Amikacin for Inhalation (LAI) in Patients With Nontuberculous Mycobacterial (NTM) Lung Infection

Pneumologie ◽  
2016 ◽  
Vol 70 (10) ◽  
Author(s):  
K Olivier ◽  
D Griffith ◽  
K Winthrop ◽  
B Brown-Elliott ◽  
G Eagle ◽  
...  
Keyword(s):  
Lung Infection ◽  
Phase 2 ◽  
Phase 2 Trial
Sign in / Sign up

Export Citation Format

Share Document